Postmarketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary Disease
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To obtain further information on the tolerability and efficacy of Atrovent® inhalets in long
term treatment of Chronic Obstructive Pulmonary Disease under conditions of daily practice